Renalytix Plc Share Price Deutsche Boerse AG
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.208 EUR | +13.04% |
|
+13.04% | +11.23% |
06-14 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
06-14 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
Sales 2024 * | 2.5M 2.33M 197M | Sales 2025 * | 9.6M 8.94M 756M | Capitalization | 33.79M 31.47M 2.66B |
---|---|---|---|---|---|
Net income 2024 * | -33M -30.73M -2.6B | Net income 2025 * | -26M -24.21M -2.05B | EV / Sales 2024 * | 13.5 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.52 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 day | +13.04% | ||
1 week | +13.04% | ||
Current month | +21.64% | ||
1 month | -20.00% | ||
3 months | -39.53% | ||
6 months | +25.30% | ||
Current year | +11.23% |
![Extreme 0.183](/images/extremecours_fleche.png)
![Extreme 0.159](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 14/03/18 |
Howard Doran
PSD | President | 63 | 31/08/23 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 14/03/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 29/08/21 |
Chairman | 72 | 14/03/18 | |
James McCullough
FOU | Founder | 56 | 14/03/18 |
Date | Price | Change |
---|---|---|
14/06/24 | 0.208 | +13.04% |
13/06/24 | 0.184 | 0.00% |
12/06/24 | 0.184 | 0.00% |
11/06/24 | 0.184 | 0.00% |
Delayed Quote Deutsche Boerse AG, June 14, 2024 at 02:29 pm
More quotes![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.80% | 16.07B | |
-51.68% | 2.43B | |
+27.39% | 2.02B | |
-7.02% | 1.53B | |
+27.90% | 1.29B | |
-20.72% | 931M | |
-32.14% | 772M | |
0.00% | 761M | |
-25.90% | 619M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock